Study to Evaluate the Efficacy and Safety of Fexuprazan in Prevention of NSAIDs Induced Peptic Ulcer
Clinical trial NCT07533266 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07533266
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-01
- Primary completion
- 2027-12-01
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.